This webinar, in Partnership with MAPS, is a virtual panel discussion where experts will describe and debate the contributions that Medical Affairs can make to early R&D (preclinical through Ph-IIb).

Topics can include:

1. Anchoring R&D in a deep understanding of the disease and current approaches to treatment;
2. Understanding the science behind the treatment;
3. Identifying clinical, functional and economic endpoints relevant to value demonstration;
4. Capturing the voice of the patient, caregiver and healthcare professionals;
5. Augmenting investigator and site selection for clinical trials; and
6. Strategies to engage key stakeholders including patients and prescribers.

Objectives:

In this webinar, you will learn how to:

1. Identify and explore additional value drivers for Medical Affairs in biopharma organizations
2. Build alignment towards common goals and initiate appropriate collaboration between Medical Affairs and R&D